EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Current options in the management of tree nut allergy: A systematic review and narrative synthesis

Maria Pasioti iD, Paraskevi Xepapadaki iD, Alexander G Mathioudakis, John Lakoumentas, Elvira Efstathiou, Nikolaos G Papadopoulos

Pediatric Allergy and Immunology · 2024

DOI: 10.1111/pai.14132 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Maria Pasioti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Department, 2nd Paediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Nut Hypersensitivity, Immunoglobulin E, Desensitization, Immunologic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute for Health and Care Research Manchester Biomedical Research Centre (NIHR Manchester BRC), NIHR Clinical Lectureship in Respiratory Medicine, Hellenic Society of Allergology and Clinical Immunonlogy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tree nut allergy is a lifelong and potentially life‐threatening condition. The standard of care is strictly avoiding the culprit nut and treating accidental reactions symptomatically. To evaluate potential therapeutic options for desensitizing patients with IgE‐mediated tree nut allergy, we systematically searched three bibliographic databases for studies published until January 2024. We looked for active treatments of IgE‐mediated allergy to tree nuts (walnut, hazelnut, pistachio, cashew, almond, pecan, macadamia nut, and brazil nut). We focused on allergen‐specific immunotherapy (AIT) using oral (OIT), sublingual (SLIT), epicutaneous (EPIT), or subcutaneous (SCIT) delivery, or other disease‐modifying treatments. We found 19 studies that met our criteria: 3 studies investigated sublingual immunotherapy, 5 studied oral immunotherapy to a single tree nut, and 6 used multi‐food oral immunotherapy with or without omalizumab. The remaining studies investigated the effectiveness of monoclonal antibodies or IgE‐immunoadsorption in multi‐food allergic patients, including patients with tree nut allergy. The heterogeneity of the studies prevented pooling and meta‐analysis. Oral immunotherapy, single or multi‐nut, with or without omalizumab, was the most studied approach and appears effective in conferring protection from accidental exposures. Omalizumab monotherapy is the only approved alternative management for reducing allergic reactions that may occur with accidental exposure. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nut HypersensitivityImmunoglobulin EDesensitization, ImmunologicHumansAllergensNutsChildOmalizumab

Stichwörter der Autor:innen

allergy treatmentfood allergyimmunotherapymanagementtree nuts

Substanzen

Immunoglobulin EAllergensOmalizumab

Autor:innen und Institutionen

  • Allergy Department, 2nd Paediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.
  • Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

ORCID-Profile: Maria Pasioti, Paraskevi Xepapadaki

Förderung

  • National Institute for Health and Care Research Manchester Biomedical Research Centre (NIHR Manchester BRC)
  • NIHR Clinical Lectureship in Respiratory Medicine
  • Hellenic Society of Allergology and Clinical Immunonlogy
  • European Social Fund-ESF) through the Operational Programme "Human Resources Development, Education and Lifelong Learning" in the context of the Act "Enhancing…
  • Manchester Biomedical Research Centre

Zitieren

APA

Pasioti, M., Xepapadaki, P., Mathioudakis, A. G., Lakoumentas, J., Efstathiou, E., & Papadopoulos, N. G. (2024). Current options in the management of tree nut allergy: A systematic review and narrative synthesis. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14132

Vancouver

Pasioti M, Xepapadaki P, Mathioudakis AG, Lakoumentas J, Efstathiou E, Papadopoulos NG. Current options in the management of tree nut allergy: A systematic review and narrative synthesis. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14132

BibTeX
@article{Pasioti2024,
  author = {Pasioti, Maria and Xepapadaki, Paraskevi and Mathioudakis, Alexander G and Lakoumentas, John and Efstathiou, Elvira and Papadopoulos, Nikolaos G},
  title = {Current options in the management of tree nut allergy: A systematic review and narrative synthesis},
  journal = {Pediatric Allergy and Immunology},
  year = {2024},
  doi = {10.1111/pai.14132}
}
Kostenlos starten →